Lucía Pérez–Carbonell

Author

Hospital General Universitario de Alicante Doctor Balmis

Also Known As

L Perez-Carbonell, L. Perez-Carbonell, L. Pérez-Carbonell, Lucia Perez-Carbonell, Lucia Pérez-Carbonell, Lucía Pérez-Carbonell, Lucía Pérez-Carbonell, Lucía Pérez–Carbonell

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Hospital General Universitario de Alicante Doctor Balmis Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Hospital General Universitario de Elche Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Hospital Del Mar

About

Lucía Pérez–Carbonell is an author at Hospital General Universitario de Alicante Doctor Balmis specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	586
2	Pathology	6	6	586
3	Public Health	1	1	215
4	Epidemiology	1	1	215
5	Cancer Therapeutics	1	1	203

Lucía Pérez–Carbonell

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Risk of Cancer in Cases of Suspected Lynch Syndrome Without Germline Mutation María Rodríguez–Soler, Lucía Pérez–Carbonell, Carla Guarinós, Gastroenterology EpidemiologySomatic VariantCancer PathologyCancer RiskGenetic Disorder	2013	215
5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer Rodrigo Jover, Thuy‐Phuong Nguyen, Lucía Pérez–Carbonell, Gastroenterology OncologyColorectal CancerPathologyCancer TreatmentMedicine	2010	203
Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer Lucía Pérez–Carbonell, Clara Ruíz-Ponte, Carla Guarinós, Gut	2011	187
Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers Cecilia Egoavil, Cristina Alenda, Adela Castillejo, PLoS ONE	2013	114
Methylation Analysis of MLH1 Improves the Selection of Patients for Genetic Testing in Lynch Syndrome Lucía Pérez–Carbonell, Cristina Alenda, Artemio Payá, Journal of Molecular Diagnostics Genetic TestingMendelian DisorderGenetic DisorderMedicineGenetics	2010	79
MiR-320e is a novel prognostic biomarker in colorectal cancer Lucía Pérez–Carbonell, Frank A. Sinicrope, S R Alberts, British Journal of Cancer	2015	71
HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in <i>BRAF</i> -Mutant Colorectal Cancer by Downregulation of c-FLIPL Robbie Carson, Başak Çeltikçi, Cathy Fenning, Clinical Cancer Research	2015	67
Prevalence and Characteristics of <i>MUTYH</i> -Associated Polyposis in Patients with Multiple Adenomatous and Serrated Polyps Carla Guarinós, Míriam Juárez, Cecilia Egoavil, Clinical Cancer Research	2014	66
IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer Lucía Pérez–Carbonell, Francesc Balaguer, Yuji Toiyama, PLoS ONE	2014	55
Prevalence of<i>MLH1</i>constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer Adela Castillejo, Eva Hernández‐Illán, María Rodríguez–Soler, Journal of Medical Genetics	2015	37

Page 1